Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen

Cancer Science

Volumn 95, Issue 6, 2004, Pages 469-474

  Tsujimura, Kunio ^a   Obata, Yuichi ^b   Takahashi, Toshitada ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b RIKEN BIORESOURCE CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; LEUKEMIA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TETRAMER; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNIZATION; CANCER INHIBITION; CELL GROWTH; CHIMERA; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC TRANSFECTION; HUMAN; IN VIVO STUDY; INTESTINE; INTESTINE LYMPHATIC TISSUE; LEUKEMIA; LYMPHOMA CELL; MOUSE STRAIN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RESTRICTION; REVIEW; SEROLOGY; SKIN CELL; T CELL LYMPHOMA; THYMOCYTE; THYMUS; TRANSGENIC MOUSE; TUMOR DIFFERENTIATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, NEOPLASM; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNIZATION, PASSIVE; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 3042596166     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03234.x     Document Type: Review

References (36)

1. Chen Y-T, Obata Y, Stockert E, Takahashi T, Old LJ. Tla-region genes and their products. Immunol Res 1987; 6: 30-45.
2. Flaherty L, Elliott E, Tine JA, Walsh AC, Waters JB. Immunogenetics of the Q and TL regions of the mouse. Crit Rev Immunol 1990; 10: 131-75.
3. Teitell M, Cheroutre H, Panwala C, Holcombe H, Eghtesady P, Kronenberg M. Structure and function of H-2 T(Tla) region class I MHC molecules. Crit Rev Immunol 1994; 14: 1-27.
4. 2-microglobulin-associated thymus-leukemia antigen is independent of TAP2. Eur J Immunol 1995; 25: 1001-7.
5. Tsujimura K, Takahashi T, Morita A, Hasegawa-Nishiwaki H, Iwase S, Obata Y. Positive selection of γδ CTL by TL antigen expressed in the thymus. J Exp Med 1996; 184: 2175-84.
6. Obata Y, Satta Y, Moriwaki K, Shiroishi T, Hasegawa H, Takahashi T, Takahata N. Structure, function, and evolution of mouse TL genes, nonclassical class I genes of the major histocompatibility complex. Proc Natl Acad Sci USA 1994; 91: 6589-93.
7. Yokoyama K, Stockert E, Old LJ, Nathenson SG. Structural comparisons of TL antigens derived from normal and leukemia cells of TL+ and TL- strains and relationship to genetically linked H-2 major histocompatibility complex products. Proc Natl Acad Sci USA 1981; 78: 7078-82.
8. 2-microblobulin. Immunogenetics 1982; 15: 543-9.
9. McIntyre KR, Hämmerling U, Uhr JW, Vitetta ES. Structural characteristics of thymus-leukemia (TL) antigens in the mouse. J Immunol 1982; 128: 1712-7.
10. Holcombe HR, Castaño AR, Cheroutre H, Teitell M, Maher JK, Peterson PA, Kronenberg, M. Nonclassical behavior of the thymus leukemia antigen: peptide transporter-independent expression of a nonclassical class I molecule. J Exp Med 1995; 181: 1433-43.
11. +) T cells that express αβ T cell receptors in transporters associated with antigen presentation-1 null and thymus leukemia antigen positive mice. J Exp Med 1996; 184: 1579-84.
12. Tsujimura K, Obata Y, Iwase S, Matsudaira, Y, Ozeki S, Takahashi T. The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent. Int Immunol 2000; 12: 1217-25.
13. Liu Y, Xiong Y, Naidenko OV, Liu J-H, Zhang R, Joachimiak A, Kronenberg M, Cheroutre H, Reinherz EL, Wang J-H. The crystal structure of a TL/ CD8αα complex at 2.1 Å resolution: implications for modulation of T cell activation and memory. Immunity 2003; 18: 205-15.
14. Hershberg R, Eghtesady P, Sydora B, Brorson K, Cheroutre H, Modlin R, Kronenberg M. Expression of the thymus leukemia antigen in mouse intestinal epithelium. Proc Natl Acad Sci USA 1990; 87: 9727-31.
15. Wu M, Van Kaer L, Itohara S, Tonegawa S. Highly restricted expression of the thymus leukemia antigens on intestinal epithelial cells. J Exp Med 1991; 174: 213-8.
16. Old LJ, Boyse EA, Stockert E. Antigenic properties of experimental leukemias. I. Serological studies in vitro with spontaneous and radiation-induced leukemias. J Natl Cancer Inst 1963; 31: 977-86.
17. Boyse EA, Old LJ, Luell S. Antigenic properties of experimental leukemias. II. Immunological studies in vivo with C57BL/6 radiation-induced leukemias. J Natl Cancer Inst 1963; 31: 987-95.
18. Old LJ, Stockert E. Immunogenetics of cell surface antigens of mouse leukemia. Annu Rev Genet 1977; 11: 127-60.
19. Morita A, Takahashi T, Stockert E, Nakayama E, Tsuji T, Matsudaira Y, Old LJ, Obata Y. TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells. J Exp Med 1994; 179: 777-84.
20. Iwase S, Tsujimura K, Matsudaira Y, Ozeki S, Onozaki K, Obata Y, Takahashi T. Comparison of anti-tumor responses against TL positive lymphoma induced by skin grafting and dendritic cell immunization. Microbiol Immunol 2000; 44: 609-18.
21. Tsujimura K, Takahashi T, Iwase S, Matsudaira Y, Kaneko Y, Yagita H, Obata Y. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements. J Immunol 1998; 160: 5253-61.
22. Hamasima N, Takahashi T, Taguchi O, Nishizuka Y, Stockert E, Old LJ, Obata Y. Expression of TL, H-2, and chimeric H-2/TL genes in transgenic mice: abnormal thymic differentiation and T-cell lymphomas in a TL transgenic strain. Proc Natl Acad Sci USA 1989; 86: 7995-9.
23. Tsuji K, Obata Y, Takahashi T, Arata J, Nakayama E. Requirement of CD4 T cells for skin graft rejection against thymus leukemia antigen and multiple epitopes on the TL molecule recognized by CD4 T cells. J Immunol 1997; 159: 159-66.
24. Weber DA, Attinger A, Kemball CC, Wigal JL, Pohl J, Reinherz EL, Cheroutre H, Kronenberg M, Jensen PE. Peptide-independent folding and CD8αα binding by the nonclassical class I molecule, thymic leukemia antigen. J Immunol 2002; 169: 5708-14.
25. Tsujimura K, Obata Y, Kondo E, Nishida K, Matsudaira Y, Akatsuka Y, Kuzushima K, Takahashi T. Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the α1/α2 domain of TL free from antigenic peptides. Int Immunol 2003; 15: 1319-26.
26. Tsujimura K, Obata Y, Matsudaira Y, Ozeki S, Yoshikawa K, Saga S, Takahashi T. The binding of thymus leukemia (TL) antigen tetramers to normal intestinal intraepithelial lymphocytes and thymocytes. J Immunol 2001; 167: 759-64.
27. Leishman AJ, Naidenko OV, Attinger A, Koning F, Lena CJ, Xiong Y, Chang HC, Reinherz E, Kronenberg M, Cheroutre H. T cell responses modulated through interaction between CD8αα and the nonclassical MHC class I molecule, TL. Science 2001; 294: 1936-9.
28. Moody AM, Chui D, Reche PA, Priatel JJ, Marth JD, Reinherz EL. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell 2001; 107: 501-12.
29. Daniels MA, Devine L, Miller JD, Moser JM, Lukacher AE, Altman JD, Kavathas P, Hogquist KA, Jameson SC. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 2001; 15: 1051-61.
30. Baum LG. Developing a taste for sweets. Immunity 2002; 16: 5-8.
31. Obata Y, Taguchi O, Matsudaira Y, Hasegawa H, Hamasima N, Takahashi T. Abnormal thymic development, impaired immune function and γδ T cell lymphomas in a TL transgenic mouse strain. J Exp Med 1991; 174: 351-62.
32. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethe B, Coulie P, Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178: 489-95.
33. Robbins PF, el-Gamil M, Kawakami Y, Stevens E, Yannelli JR, Rosenberg SA. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 1994; 54: 3124-6.
34. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298: 850-4.
35. Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003; 15: 138-47.
36. Margulies DH. TCR avidity: it's not how strong you make it, it's how you make it strong. Nat Immunol 2001; 2: 669-70.